Lupin protein isolate versus casein modifies cholesterol excretion and mRNA expression of intestinal sterol transporters in a pig model
© Radtke et al.; licensee BioMed Central Ltd. 2014
Received: 19 November 2013
Accepted: 28 January 2014
Published: 3 February 2014
Lupin proteins exert hypocholesterolemic effects in man and animals, although the underlying mechanism remains uncertain. Herein we investigated whether lupin proteins compared to casein modulate sterol excretion and mRNA expression of intestinal sterol transporters by use of pigs as an animal model with similar lipid metabolism as humans, and cellular cholesterol-uptake by Caco-2 cells.
Two groups of pigs were fed cholesterol-containing diets with either 230 g/kg of lupin protein isolate from L. angustifolius or 230 g/kg casein, for 4 weeks. Faeces were collected quantitatively over a 5 d period for analysis of neutral sterols and bile acids by gas chromatographically methods. The mRNA abundances of intestinal lipid transporters were analysed by real-time RT-PCR. Cholesterol-uptake studies were performed with Caco-2 cells that were incubated with lupin conglutin γ, phytate, ezetimibe or albumin in the presence of labelled [4-14C]-cholesterol.
Pigs fed the lupin protein isolate revealed lower cholesterol concentrations in total plasma, LDL and HDL than pigs fed casein (P < 0.05). Analysis of faeces revealed a higher output of cholesterol in pigs that were fed lupin protein isolate compared to pigs that received casein (+57.1%; P < 0.05). Relative mRNA concentrations of intestinal sterol transporters involved in cholesterol absorption (Niemann-Pick C1-like 1, scavenger receptor class B, type 1) were lower in pigs fed lupin protein isolate than in those who received casein (P < 0.05). In vitro data showed that phytate was capable of reducing the uptake of labelled [4-14C]-cholesterol into the Caco-2 cells to the same extend as ezetimibe when compared to control (−20.5% vs. −21.1%; P < 0.05).
Data reveal that the cholesterol-lowering effect of lupin protein isolate is attributable to an increased faecal output of cholesterol and a reduced intestinal uptake of cholesterol. The findings indicate phytate as a possible biofunctional ingredient of lupin protein isolate.
KeywordsLupin protein isolate Faecal cholesterol output Intestinal sterol transporters Cholesterol-uptake Pigs Caco-2 cells
Diets that contain lupin proteins have repeatedly been shown to lower plasma cholesterol concentrations in hypercholesterolemic rats [1–3] and humans  compared to casein. Those studies demonstrated higher protein concentration and activity of hepatic low density lipoprotein (LDL) receptor, and a transcriptional up-regulation of hepatic cholesterol 7α-hydroxylase (CYP7A1), a key enzyme involved in the synthesis of bile acids, in response to lupin proteins [1–3]. However, the mechanism by which ingested lupin proteins can alter hepatic LDL receptor and hepatic enzyme expression remains uncertain. It may be argued whether the observed alterations in liver lipid metabolism can be attributed to intact lupin polypeptides that enter the organism. However, it appears more plausible that lupin proteins and/or lupin protein-associated compounds, respectively, exert their physiological effects in the intestine which in turn indirectly alter the hepatic protein and mRNA concentrations of LDL receptor and CYP7A1. As a matter of facts, recent data demonstrate that pigs fed a diet with blue lupin seeds had lower plasma cholesterol concentrations and a higher faecal output of neutral sterols than casein fed pigs . Those authors assumed that the hypocholesterolemic effect of the blue lupin seeds, which were added to the diet as substitute for corn starch, soybean oil and casein, was attributable to impaired intestinal cholesterol absorption. However, whole lupin seeds contain not only proteins but also fibres that may have caused the increased sterol output in that study. Whether isolated lupin proteins themselves could contribute to the increased cholesterol excretion has not been demonstrated yet, though there is evidence suggesting that proteins cause these kind of effects. Ovariectomised cynomolgus monkeys that were fed isolated soybean proteins for 20 weeks absorbed less cholesterol in the intestine than monkeys which received casein alone or supplemented with soy isoflavones . In that study soybean proteins revealed a specific impact on cholesterol output, whilst the excretion of bile acids was not influenced in response to soybean proteins. In view of the considerable genetic similarity between soy and lupin, it is most likely that the cholesterol-lowering effect of lupin proteins is also caused by an increased sterol output.
The current study aimed to examine the effect of lupin protein isolate compared to casein on faecal output of neutral and acidic sterols, and on the expression of intestinal sterol transporters. Pigs were used as an animal model because morphology and physiology of the gastrointestinal system, the ingesta transit times, the digestive efficiencies and the response to hyperlipidemic diets are comparable to those of humans . Since lupin proteins have been shown to be most effective in lowering plasma cholesterol concentrations when administered together with a hypercholesterolemic diet , all pigs received a cholesterol-containing diet. Besides parameters that enable conclusions on intestinal sterol absorption, the bioavailability of minerals and fat-soluble vitamins were analysed.
Since in vitro experiments with a buckwheat protein product  and soy protein hydrolysate  showed reduced cholesterol-uptake by Caco-2 cells compared to control, similar experiments were conducted to investigate which component of the lupin protein isolate is responsible for the lipid lowering effect. To this aim, Caco-2 cells were incubated with pure conglutin γ, a candidate cholesterol-lowering lupin seed protein in force of its ability to reduce the LDL receptor activity in HepG2 cells , and phytate, which naturally occurs in isolates of plant proteins like lupin proteins. Incubations were performed in the presence of radiolabelled [4-14C]-cholesterol to quantify the cholesterol-uptake.
Animals, diet and design
Twenty-four 12 weeks old female crossbred pigs [(German Landrace × Large White) x Pietrain] with an initial body weight of 34.9 ± 1.9 kg (mean ± SD) were randomly assigned to 2 groups of 12 pigs each. The animals received a hypercholesterolemic basal diet, one group with 230 g/kg lupin protein isolate from L. angustifolius and the other group (control) with 230 g/kg casein (Meggle, Wasserburg, Germany). The diets were fed for 4 weeks. Besides the experimental proteins, the hypercholesterolemic basal diet contained (in g/kg diet) wheat (400), corn starch (casein diet: 197; lupin protein diet: 192), coconut fat (120), cholesterol (20), vitamin and mineral mixture (20) and monocalcium phosphate (13). The lupin protein diet was supplemented additionally with 5 g/kg of DL-methionine at the expense of corn starch to meet the requirement for methionine for growing pigs . Minerals and vitamins were added according to the recommendations of the NRC  as precast mix (Mineral feed, Basu, Bad Sulza, Germany). The diets were calculated on the basis of GfE recommendations  to contain 15 MJ/kg. The pigs were individually kept in pens in an environmentally controlled facility with a temperature of 20°C, relative humidity between 55-60%, and light from 06:00 am to 06:00 pm. All pigs had free access to food. Water was available ad libitum from a nipple drinker system during the whole experiment. The pigs were weighed once a week. During the last 5 days of the experiment, six pigs of each group were kept in metabolism cages which allowed a quantitative collection of faeces. The experimental procedure was performed according to the established guidelines for care and handling of laboratory animals and was approved by the council of Saxony-Anhalt, Germany (No. 42502-2-1040MLU).
Preparation and characterisation of the experimental proteins
Casein that was used as control protein was not further processed. Defatted total protein isolate of L. angustifolius was provided by the Fraunhofer Institute (IVV, Freising, Germany). The crude protein content of the diet proteins was determined by official methods , and was 948 g/kg dry matter (DM) for casein and 915 g/kg DM for lupin protein isolate. The amino acid composition of the experimental proteins is shown in Additional file 1. Casein contained (in g/kg DM) 0.58 calcium, 2.7 phosphorus, 0.10 magnesium, and 0.056 zinc. The lupin protein isolate contained (in g/kg DM) 1.02 calcium, 9.41 phosphorus, 0.59 magnesium, and 0.032 zinc. The calculated amount of phytic acid based on the analysed phytate phosphate in the lupin protein isolate was 25.4 g/kg DM. No detectable phytate phosphate was found in casein.
Lupin conglutin γ was isolated from lupin seed flour according to Lovati et al. . The procedure consisted of various chromatographic steps, including metal affinity chromatography on NiNTA-agarose. The homogeneity of purified conglutin γ was assessed by SDS-PAGE .
Amino acid analysis of the experimental proteins
Samples were oxidised and then hydrolysed with 6 M HCl  to determine the amino acid concentrations. Separation and quantification of the amino acids were performed by ion-exchange chromatography following post-column derivatisation in an amino acid analyzer (Biotronic LC 3000; Eppendorf, Hamburg, Germany). After digesting the diets with barium hydroxide  tryptophan was quantified by reversed-phase HPLC .
Analysis of phytate phosphate and phytic acid of the experimental proteins
The concentration of phytate phosphate in the dietary proteins was analysed by a method of Harland and Oberleas . Briefly, phytic acid was extracted from 2 g protein with 40 ml 2.4% HCl. Afterwards the samples were filtered and immobilised onto an anion exchange column (AG1-X4, 100–200 mesh, chloride form, Bio-Rad Laboratories, Hercules, California, USA). After washings the retained inositol phosphates were eluted from the column with 0.7 M NaCl. A 50 μl aliquot of the eluent was hydrolysed with 50 μl of a 5 M HClO4 and 1 M H2SO4 mixture, and was ashed at 250°C. The inorganic phosphate concentration of the samples was quantified colourimetrically by use of standards. The phytic acid content of the sample was calculated to be 28.2% × phosphorus .
Blood samples that were taken from each animal at the beginning and at the end of the experiment were collected in heparinised tubes and centrifuged at 4°C and 1,100 g for 10 min to obtain plasma. Faeces were collected twice a day over a period of 5 days. Pooled faeces from each pig were frozen at −20°C pending analysis. At the end of the experimental period, the pigs were anaesthetised and killed by exsanguination 12 h after their last meal. The liver was harvested and weighed. Thirty cm of small intestine (10 cm before and 20 cm behind the papilla duodeni major) were removed, rinsed with physiological NaCl solution and cut lengthwise. The intestinal mucosa was scraped and mixed. Samples of liver and intestinal mucosa were snap-frozen in liquid nitrogen and stored at −80°C pending further analysis.
Lipoprotein isolation and lipid analysis
Plasma lipoproteins were separated according to their density (very low density lipoprotein, VLDL, ρ < 1.006 g/ml; LDL, 1.006 g/ml < ρ < 1.040 g/ml; high density lipoprotein, HDL, 1.063 g/ml < ρ < 1.21 g/ml) by step wise ultracentrifugation. Lipids from liver and freeze dried faeces were extracted with a mixture of n-hexane and isopropanol (3:2, v/v) according to the method from Hara & Radin  modified by Eder & Kirchgessner . To measure lipid concentrations of liver and faeces, aliquots of the lipid extracts were dried and residues dissolved in a mixture of Triton X-100 and chloroform (1:1, w/w). The cholesterol and triglyceride concentrations of plasma, plasma lipoproteins, liver and faeces were determined using enzymatic reagent kits (Diagnostic Systems, Holzheim, Germany).
Analysis of faecal neutral sterols and bile acids by GC-FID and GC-MS
Lyophilised aliquots of homogenised faeces were analysed for neutral sterols (cholesterol, coprostanol, cholestanol, coprostanone and cholestanone) and for bile acids (iso-lithocholic acid, lithocholic acid, chenodeoxycholic acid, hyodeoxycholic acid, hyocholic acid) according to gas chromatographically methods, which have been previously described [19, 20]. In brief, 50 mg faeces were provided with 5α-cholestane (Sigma-Aldrich, Taufkirchen, Germany) as internal standard and underwent a mild alkaline hydrolysis with freshly prepared 1 M ethanolic NaOH. Free sterols were extracted with cyclohexane, extracts were dried under nitrogen stream and residues were resolved in decane. The analysis was performed using GC-FID (GC17A-AF Vers. 3, Shimadzu Corp., Kyoto, Japan). After extraction of the neutral sterols the samples underwent a strong alkaline hydrolysis with 10 M NaOH solution. The samples were than adjusted to pH 1 with HCl and free bile acids were extracted with diethyl ether. Norcholic acid (Sigma-Aldrich) was added as internal standard and extracts were methylated, silylated and finally dried under nitrogen stream. Residues were resolved in decane and injected in the GC-MS (GC17-QP5000, Shimadzu Corp.). Bile acid quantification was based on the multi-ion detection with m/z = 253.20 for norcholic acid, m/z = 215.25 for iso-lithocholic acid and lithocholic acid, m/z = 73.10 for chenodeoxycholic acid, m/z = 255.3 for hyodeoxycholic acid, and m/z = 458.50 for hyocholic acid.
RNA isolation and real-time RT-PCR
For the determination of mRNA abundances total RNA was isolated from intestinal mucosa using Trizol™ reagent (Invitrogen, Karlsruhe, Germany) according to the manufacturer’s protocol. The RNA concentration was estimated from the optical density at 260 nm. RNA purity was proofed by agarose gel electrophoresis. A total of 1.2 μg of total RNA was used for cDNA synthesis using the RevertAid™ M-MuLV Reverse transcriptase (Thermo Fisher Scientific Inc., Waltham, MA, USA). For the determination of relative mRNA concentrations real-time detection RT-PCR using the Rotorgene 6000 system (Corbett Research, Mortlake, Australia) was applied. A total of 1 μl cDNA templates were amplified in a total volume of 20 μl using 200 μM dNTPs (Genecraft, Cologne, Germany), 1.5 mM MgCl2, 0.5 U GoTaq DNA polymerase, 4 μl 5× buffer (all from Promega, Mannheim, Germany), 0.2 μl 10× SYBR Green (Sigma-Aldrich), and 5.4 pM of each primer. The PCR protocol provided an initial denaturation at 95°C for 3 min and 20–35 cycles of amplification comprising denaturation at 95°C for 25 s, annealing at primer-specific temperatures (57-60°C) for 30 s and elongation at 72°C for 55 s. Subsequently melting curve analysis was performed from 50°C to 99°C with continuous fluorescence measurement. The amplification of a single product of the expected size was confirmed using 2% agarose gel electrophoresis. Relative mRNA concentrations were calculated using the ∆∆Ct method . Ct-values of target genes and the reference genes were obtained using Rotorgene Software 5.0. Succinate dehydrogenase, subunit A (SDHA) and ribosomal protein S9 (RPS9) served as appropriate reference genes. Relative mRNA expression was expressed as fold change of mRNA abundance relative to the casein group. Sequences of the gene-specific primers are shown in Additional file 2.
Plasma concentrations of 25-hydroxy vitamin D3 (25(OH)D3) and tocopherols
The plasma concentration of 25(OH)D3 was determined by coupled liquid chromatography-mass spectrometry (LC-MS) using a MassChrom™ reagent kit (Chromsystems, Munich, Germany) as described recently . In brief, plasma samples were mixed with deuterated 25(OH)D3 (Chemaphor Inc., Ottawa, Canada) as internal standard. Precipitation reagent was added, and subsequent to centrifugation at 15,000 g for 5 min the supernatant was transferred into a HPLC vial and analysed by HPLC (Agilent 1100 HPLC, Agilent Technologies, Waldbronn, Germany), coupled to a MS system (API 2000, Applied Biosystems, Darmstadt, Germany).
The concentration of plasma tocopherol isomers was determined by HPLC analysis . Plasma samples were mixed with 1 ml of a 0.1 g/l pyrogallol solution (ethanol, absolute) and 150 μl saturated NaOH solution. This mixture was incubated at 70°C for 30 min, and tocopherols were extracted with n-hexane. Individual tocopherols of the extracts were separated isocratically by HPLC (Agilent 1100 HPLC, Agilent Technologies) using a mixture of n-hexane and 1,4 dioxane (94:6, v/v) as mobile phase and a LiChrospher Si-60 column (5 μm particle size, 250 mm length, 4 mm internal diameter; Agilent Technologies) and detected by fluorescence (excitation wavelength 295 nm, emission wavelength 325 nm).
Analysis of plasma and faeces minerals
For the determination of calcium, phosphorus, magnesium and zinc concentrations, plasma was diluted with distilled water and faeces were hydrolysed with 6 M HCl and 1.76 M HNO3 according to the official VDLUFA method . The minerals were analysed by inductively coupled plasma optical emission spectroscopy (ICP OES; Varian 715-ES; Agilent Technologies) using selected wavelengths (Ca: 318 nm, P: 215 nm, Mg: 280 nm, Zn: 214 nm). Analyses were run in duplicates.
Cell culture experiments
Caco-2 cells were cultured in minimal essential medium (MEM) with 10% fetal bovine serum (FBS) at 37°C with 5% CO2 and passaged at 90% of confluence . For cholesterol-uptake experiments, cells were seeded in common 6 well plates at a density of 0.8 × 106 cells per well and cultured for 20 to 23 days. Cells were used for experiments from passage 17 to 27. 24 h prior to the experiments cells received serum free medium.
For the cholesterol-uptake, cells were incubated for 2 h at 37°C with 2 mM radioisotopically labelled cholesterol ([4-14C]-cholesterol, 0.1 mCi/ml, American Radiolabeled Chemicals Inc., St. Louis, MO, USA) dissolved in MEM plus 2% FBS as previously described [25, 26] with or without the following test substances: 0.04 mg/ml ezetimibe (Santa Cruz Biotechnology Inc., Heidelberg, Germany), 5 mg/ml albumin (Sigma-Aldrich), 0.6 mg/ml lupin conglutin γ or 0.18 mg/ml sodium phytate (Sigma-Aldrich). The ezetimibe concentration which we used for the incubation study ranged in the upper concentration levels of ezetimibe used in other cell culture experiments [27, 28]. Prior to the incubation, the cells were washed twice with HEPES buffer (25 mM HEPES/Tris (pH 7.5), 140 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM MgSO4, 5 mM glucose, 37°C). After the incubation, the cells were quickly washed twice with phosphate buffered saline (37°C) containing 1% bovine serum albumin and four times with ice-cold HEPES buffer. Finally, cells were dissolved in radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris/HCl (pH 8.0), 150 mM NaCl, 1% Triton X-100 (w/v), 0.5% sodium deoxycholate (w/v), 0.1% sodium dodecyl sulfate (w/v)) and the amount of absorbed radiolabelled cholesterol was determined by liquid scintillation spectrometry (Liquid Scintillation Analyser Tri-Carb 2800 TR, Perkin Elmer, Rodgau, Germany). Protein concentration was measured using BC assay (Uptima, Interchim, Montlucon, France). Data are expressed as pmol of cholesterol per mg of cell protein.
Values are expressed as means ± SD. Means of the two groups were compared by Student’s t-test using the statistic software MINITAB (Release 13, Minitab Ltd., Michigan, USA). Significances of differences between basal and final means were tested by the paired t-test. Means were considered significantly different at P < 0.05.
Daily food intake and final body mass of pigs
Daily food intake (casein group: 1.22 ± 0.04 kg/d; lupin protein group: 1.23 ± 0.03 kg/d) and final body mass (casein group: 49.0 ± 3.0 kg; lupin protein group: 48.8 ± 2.4 kg) did not differ between the two groups of pigs.
Plasma and liver lipids
Faecal excretion of triglycerides, neutral sterols and bile acids
Relative mRNA concentrations of intestinal sterol transporters and receptors
Plasma 25-hydroxy vitamin D3 and plasma tocopherol
Plasma mineral concentrations and faecal output of minerals
Cholesterol-uptake by Caco-2 cells
The current study with pigs as a model for human gastrointestinal and lipid physiology reveals hypocholesterolemic effects of lupin protein isolate compared to casein, and confirms previous findings from lupin protein studies with hypercholesterolemic rats and humans [2, 4]. We found that lupin protein fed pigs had lower levels of both, the undesirable LDL cholesterol and the favourable HDL cholesterol, compared to pigs that received casein, which in turn resulted in comparable ratios of total to HDL cholesterol and LDL to HDL cholesterol in both groups of pigs. Considering the fact that those ratios are much better predictors of risk of heart diseases than LDL or total cholesterol levels alone, we assume that the cholesterol-lowering properties of lupin protein isolate may not be inevitably associated with a risk reduction of cardiovascular diseases. Faeces analyses from this study showed that the reduction of circulating plasma cholesterol concentrations in response to lupin protein isolate administration was associated with a significant increase of faecal cholesterol output. We therefore assume that the increased faecal cholesterol excretion in the lupin protein group compared to the casein group was –at least partially– responsible for the reduced concentrations of circulating plasma, LDL and HDL cholesterol in these pigs. As there are no differences between the two groups in the relative mRNA abundance of ApoA1, which is a major protein component of HDL, we assume that the intestinal ApoA1 expression is not the leading cause for the observed HDL lowering effects. Data further show that the faecal output of bile acids, and also coprostanol, cholestanol, coprostanone, and cholestanone, which normally arise from the conversion of cholesterol in the gut by intestinal bacteria , was not altered in response to the treatment with lupin protein isolate. In this study we used extremely high amounts of dietary cholesterol (2%), we may therefore assume that the capacity of coprostanoligenic bacteria to convert cholesterol to coprostanol was not high enough for further increase of the faecal coprostanol content in the lupin protein fed group.
Different factors could have caused the increased output of faecal cholesterol in the lupin protein group: (1) lupin protein isolate compared to casein could have affected the cholesterol absorption by modifying sterol transporter expression in the intestine, (2) lupin protein isolate could have un-specifically bound sterols in the gut lumen which in consequence increased cholesterol output, (3) lupin protein isolate could have contributed to an increased excretion of cholesterol via the bile, (4) lupin protein isolate could have influenced formation, solubility or composition of micelles which in turn affected cholesterol-uptake into the enterocytes or (5) lupin protein isolate could have affected the cholesterol efflux via modification of basolateral sterol transporter expression in the intestine. Several intestinal transporters are involved in trafficking cholesterol across the apical enterocyte membrane such as SR-BI , FAT/CD36 , NPC1L1  and ABC transporters . All of these transporters have been found to be regulated by transcription . Here we show that lupin protein isolate, compared to casein, down-regulated the mRNA abundances of intestinal sterol transporters, especially those which catalyse the cholesterol-uptake. This is further supported by the fact that lupin protein fed pigs tended to have lower mRNA expression of the cholesterol responsive nuclear receptor LXRα and its responsive gene ABCA1 which are indicative of reduced intracellular cholesterol in the intestinal cells of these animals. Similar effects on LXRα and ABCA1 expression were also observed in hyperinsulinemic obese Zucker rats that were fed with soy protein . Thus, the mRNA data of the current experiment are indicative of a lower intestinal cholesterol absorption following intake of lupin protein isolate, and not of an altered cholesterol efflux.
There is a growing body of evidence that certain proteins such as those from buckwheat seeds , egg white , silk protein sericin  and soystatin, a novel peptide derived from soybean protein , may influence the incorporation of cholesterol into micelles. Nagaoka et al. could show that the soybean protein derived Val-Ala-Trp-Trp-Met-Tyr peptide, designated soystatin, inhibits cholesterol absorption by reducing the micellar solubility of cholesterol . Lupin is genetically similar to soybean and one can assume that the diminished solubilisation of cholesterol in micelles may also occur in response to ingested lupin proteins. Intriguingly, soystatin arises from glycinin, the soybean 11S globulin, and the lupin homologous protein [UniProt:Q53I54] does contain a resembling sequence, namely Ile-Pro-Phe-Trp-Met-Tyr between amino acids 152 and 157. Polar lipids such as fatty acids are normally well absorbed from emulsions, and incorporation of polar lipids into mixed micelles is not necessarily a prerequisite for their absorption . However, the formation of micelles is essential for the absorption of cholesterol and fat-soluble vitamins, because those non-polar lipids, which position themselves between the oil and the micellar phase, must be carried by micelles to the brush border membrane . Analyses of the plasma concentrations of 25(OH)D3 and tocopherols indicate negative impacts of lupin protein isolate on micellar transport system because changes of plasma concentrations of both vitamins in response to lupin protein isolate revealed a trend toward lower values compared to casein. On the other hand there are particles in the plasma, like LDL, which contain tocopherols. Therefore, the decreased LDL cholesterol concentrations of pigs fed lupin protein isolate compared to those fed casein could also explain the lower plasma α-tocopherol concentrations.
Another biofunctional molecule which is naturally associated with the lupin protein isolate is phytic acid. Phytic acid is suggested to possess also hypocholesterolemic properties. Lee and co-workers found that diabetic KK mice that were fed diets supplemented with 0.5, 1.0, and 1.5% of phytic acid developed a dose-dependent reduction of plasma cholesterol concentrations that was mainly caused by LDL reduction . Phytic acid also developed plasma cholesterol-lowering activity in tilapia  and rats fed a high-sucrose diet , and increased faecal cholesterol and bile acid excretion in rats and mice [44, 45]. Koba et al.  investigated the influence of phytate on the cholesterol-lowering effect of soy protein. Thereby, rats fed a cholesterol-enriched diet with soy protein and phytate-replenished soy protein showed significantly lower serum and liver cholesterol concentrations than rats fed casein and phytate-depleted soy protein. Analysis of the lupin protein isolate which we used for the pig study contained 25 g/kg phytic acid which corresponds to an additional content of 0.57% phytic acid in the lupin protein diet. Seeds of legumes naturally contain relatively high amounts of phytic acid [47–49], and food technology processes which are used to isolate proteins from plants normally do not separate phytic acid from the proteins. Phytate serves as storage of phosphorus for the plant kernels and has been regarded as an antinutrient because it inhibits the absorption of essential trace elements and minerals (for review see Schlemmer et al. ). However, growing evidence indicates that phytic acid exerts also beneficial effects such as antioxidative functions [51, 52], and antitumor activity . Data from our in vitro experiment show that phytate was capable of reducing the cellular cholesterol-uptake to a similar magnitude as ezetimibe, a known cholesterol absorption inhibitor , whereas conglutin γ was non-effective. Thus, we assume that phytate associated with the lupin protein isolate could have contributed to the observed cholesterol-lowering effect in the group fed the lupin protein diet. However, the increased faecal output of calcium and magnesium and the lower plasma concentrations of both minerals, therefore, constitute an undesirable side effect of the cholesterol-lowering activity of lupin protein isolate-associated phytate.
Collectively, the current data show that lupin protein isolate compared to casein stimulates faecal output of cholesterol which is suggested to be responsible for the cholesterol-lowering effect of lupin proteins. The findings that lupin protein isolate treated pigs had reduced relative mRNA concentrations of intestinal NPC1L1 and SR-BI and lower plasma concentrations of fat-soluble vitamins support the assumption that lupin proteins negatively affect intestinal cholesterol absorption. The cholesterol-uptake data provide evidence that associated phytate could – at least partly – contribute to the observed cholesterol-lowering effect of lupin protein isolate.
ATP-binding cassette transporter
Fatty acid translocase/cluster determinant 36
Fetal bovine serum
Flame ionization detector
Farnesoid X receptor
Liver X receptor α
High density lipoprotein
Inductively coupled plasma optical emission spectroscopy
Low density lipoprotein
Minimum essential medium
Niemann-Pick C1-like 1
Ribosomal protein S9
Succinate dehydrogenase, subunit A
Scavenger receptor class B, type 1
Very low density lipoprotein
25-hydroxy vitamin D3.
The present study was supported by grant from the Federal Ministry of Education and Research of Germany (0315683B).
- Sirtori CR, Lovati MR, Manzoni C, Castiglioni S, Duranti M, Magni C, Morandi S, D’Agostina a, Arnoldi A: Proteins of white lupin seed, a naturally isoflavone-poor legume, reduce cholesterolemia in rats and increase LDL receptor activity in HepG2 cells. J Nutr. 2004, 134: 18-23.
- Bettzieche A, Brandsch C, Weisse K, Hirche F, Eder K, Stangl GI: Lupin protein influences the expression of hepatic genes involved in fatty acid synthesis and triacylglycerol hydrolysis of adult rats. Br J Nutr. 2008, 99: 952-962.View Article
- Bettzieche A, Brandsch C, Eder K, Stangl GI: Lupin protein acts hypocholesterolemic and increases milk fat content in lactating rats by influencing the expression of genes involved in cholesterol homeostasis and triglyceride synthesis. Mol Nutr Food Res. 2009, 53: 1134-1142. 10.1002/mnfr.200800393.View Article
- Weisse K, Brandsch C, Zernsdorf B, Nkengfack Nembongwe GS, Hofmann K, Eder K, Stangl GI: Lupin protein compared to casein lowers the LDL cholesterol: HDL cholesterol-ratio of hypercholesterolemic adults. Eur J Nutr. 2010, 49: 65-71. 10.1007/s00394-009-0049-3.View Article
- Martins JM, Riottot M, de Abreu MC, Viegas-Crespo AM, Lanҫa MJ, Almeida JA, Freire JB, Bento OP: Cholesterol-lowering effects of dietary blue lupin (Lupinus angustifolius L.) in intact and ileorectal anastomosed pigs. J Lipid Res. 2005, 46: 1539-1547. 10.1194/jlr.M500129-JLR200.View Article
- Greaves KA, Wilson MD, Rudel LL, Williams JK, Wagner JD: Consumption of soy protein reduces cholesterol absorption compared to casein protein alone or supplemented with an isoflavone extract or conjugated equine estrogen in ovariectomized cynomolgus monkeys. J Nutr. 2000, 130: 820-826.
- Miller ER, Ullrey DE: The pig as a model for human nutrition. Annu Rev Nutr. 1987, 7: 361-382. 10.1146/annurev.nu.07.070187.002045.View Article
- Metzger BT, Barnes DM, Reed JD: A buckwheat protein product (BWP) decreases micellar cholesterol solubility and delivery to Caco-2 cells [Meeting Abstract Supplement]. FASEB J. 2006, 20: A1024-10.1096/fj.05-5288fje.View Article
- Nagaoka S, Miwa K, Eto M, Kuzuya Y, Hori G, Yamamoto K: Soy protein peptic hydrolysate with bound phospholipids decreases micellar solubility and cholesterol absorption in rats and Caco-2 cells. J Nutr. 1999, 129: 1725-1730.
- NRC: Nutrient requirements of swine. 1998, Washington, D.C: National Academy Press, 10
- Gesellschaft für Ernährungsphysiologie: Empfehlungen zur Energie- und Nährstoffversorgung von Schweinen. 2006, Frankfurt am Main: DLG-Verlag
- Bassler R: Die chemische Untersuchung von Futtermitteln, vol. 3. 1976, Methodenbuch. Darmstadt: VDLUFA-Verlag, 3
- Lovati MR, Manzoni C, Castiglioni S, Parolari A, Magni C, Duranti M: Lupin seed γ-conglutin lowers blood glucose in hyperglycaemic rats and increases glucose consumption of HepG2 cells. Br J Nutr. 2012, 107: 67-73. 10.1017/S0007114511002601.View Article
- Fontaine J, Bech-Andersen S: Determination of tryptophan in feed by HPLC – development of an optimal hydrolysis and extraction procedure by the EU commission DG XII in three international collaborative studies. Agribiol Res. 1998, 51: 97-108.
- Eder K, Peganova S, Kluge H: Studies on the tryptophan requirement of piglets. Arch Tierernahr. 2001, 55: 281-297. 10.1080/17450390109386198.View Article
- Harland BF, Oberleas D: Anion exchange method for determination of phytate in foods: collaborative study. J Assoc Off Anal Chem. 1986, 69: 667-670.
- Hara A, Radin NS: Lipid extraction of tissues with a low-toxicity solvent. Anal Biochem. 1978, 90: 420-426. 10.1016/0003-2697(78)90046-5.View Article
- Eder K, Kirchgessner M: Levels of polyunsaturated fatty acids in tissues from zinc-deficient rats fed a linseed oil diet. Lipids. 1994, 29: 839-844. 10.1007/BF02536251.View Article
- Keller S, Helbig D, Härtl A, Jahreis G: Nanoscale and customary non-esterified sitosterols are equally enriched in different body compartments of the guinea pig. Mol Nutr Food Res. 2007, 51: 1503-1509. 10.1002/mnfr.200700237.View Article
- Keller S, Jahreis G: Determination of underivatised sterols and bile acid trimethyl silyl ether methyl esters by gas chromatography–mass spectrometry-single ion monitoring in faeces. J Chromatogr B Analyt Techno Biomed Life Sci. 2004, 813: 199-207. 10.1016/j.jchromb.2004.09.046.View Article
- Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2 (−Delta delta C (T)) method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.View Article
- Schmidt N, Brandsch C, Kühne H, Hirche F, Stangl GI: Vitamin D receptor deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in mice. PLoS One. 2012, 7: e35316-10.1371/journal.pone.0035316.View Article
- Balz MK, Schulte E, Thier HP: Simultaneous determination of α-tocopheryl acetate, tocopherols and tocotrienols by HPLC with fluorescence detection in foods. Fett Wiss Technol. 1993, 95: 215-220.
- Hellwig M, Geissler S, Peto A, Knütter I, Brandsch M, Henle T: Transport of free and peptide-bound pyrraline at intestinal and renal epithelial cells. J Agric Food Chem. 2009, 57: 6474-6480. 10.1021/jf901224p.View Article
- Brauner R, Johannes C, Ploessl F, Bracher F, Lorenz RL: Phytosterols reduce cholesterol absorption by inhibition of 27-hydroxycholesterol generation, liver x receptor α activation, and expression of the basolateral sterol exporter APT-binding cassette A1 in Caco-2 enterocytes. J Nutr. 2012, 142: 981-989. 10.3945/jn.111.157198.View Article
- Rode S, Rubic T, Lorenz RL: alpha-Tocopherol disturbs macrophage LXRalpha regulation of ABCA1/G1 and cholesterol handling. Biochem Biophys Res Commun. 2008, 369: 868-872. 10.1016/j.bbrc.2008.02.132.View Article
- Feng D, Ohlsson L, Duan RD: Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expression. Lipids Health Dis. 2010, 9: 40-10.1186/1476-511X-9-40.View Article
- Yamanashi Y, Takada T, Suzuki H: Niemann-Pick C1-like 1 overexpression facilitates ezetimibe-sensitive cholesterol and β-sitosterol uptake in CaCo-2 cells. J Pharmacol Exp Ther. 2007, 320: 559-564.View Article
- Grimalt JO, Fernandez P, Bayona JM, Albaiges J: Assessment of fecal sterols and ketones as indicators of urban sewage inputs to coastal waters. Environ Sci Technol. 1990, 24: 357-363. 10.1021/es00073a011.View Article
- Cai L, Eckhardt ERM, Shi W, Zhao Z, Nasser M, de Villiers WJ, van der Westhuyzen DR: Scavenger receptor class B type I reduces cholesterol absorption in cultured enterocyte Caco-2 cells. J Lipid Res. 2004, 45: 253-262.View Article
- Werder M, Han CH, Wehrli E, Bimmler D, Schulthess G, Hauser H: Role of scavenger receptors SR-BI and CD36 in selective sterol uptake in the small intestine. Biochemistry. 2001, 40: 11643-11650. 10.1021/bi0109820.View Article
- Davis HR, Zhu LJ, Hoos LM, Tetzloff G, Maguire M, Liu J, Yao X, Iyer SP, Lam MH, Lund EG, Detmers PA, Graziano MP, Altmann SW: Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem. 2004, 279: 33586-33592. 10.1074/jbc.M405817200.View Article
- Brewer HB, Santamarina-Fojo S: New insights into the role of the adenosine triphosphate-binding cassette transporters in high-density lipoprotein metabolism and reverse cholesterol transport. Am J Cardiol. 2003, 91: 3E-11E.View Article
- Brown JM, Yu L: Protein mediators of sterol transport across intestinal brush border membrane. Subcell Biochem. 2010, 51: 337-380. 10.1007/978-90-481-8622-8_12.View Article
- Tovar AR, Torre-Villalvazo I, Ochoa M, Elías AL, Ortíz V, Aguilar-Salinas CA, Torres N: Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats. J Lipid Res. 2005, 46: 1823-1832. 10.1194/jlr.M500067-JLR200.View Article
- Matsuoka R, Kimura M, Muto A, Masuda Y, Sato M, Imaizumi K: Mechanism for the cholesterol-lowering action of egg white protein in rats. Biosci Biotechnol Biochem. 2008, 72: 506-1512. 10.1271/bbb.70588.View Article
- Limpeanchob N, Trisat K, Duangjai A, Tiyaboonchai W, Pongcharoen S, Sutheerawattananonda M: Sericin reduces serum cholesterol in rats and cholesterol uptake into caco-2 cells. J Agric Food Chem. 2010, 58: 12519-12522. 10.1021/jf103157w.View Article
- Nagaoka S, Nakamura A, Shibata H, Kanamaru Y: Soystatin (VAWWMY), a novel bile acid-binding peptide, decreased micellar solubility and inhibited cholesterol absorption in rats. Biosci Biotechnol Biochem. 2010, 74: 1738-1741. 10.1271/bbb.100338.View Article
- Simmonds WJ, Redgrave TG, Willix RL: Absorption of oleic and palmitic acids from emulsions and micellar solutions. J Clin Invest. 1968, 47: 1015-1025. 10.1172/JCI105791.View Article
- Borgström B: Partition of lipids between emulsified oil and micellar phases of glyceride-bile salt dispersions. J Lipid Res. 1967, 8: 598-608.
- Lee SH, Park HJ, Chun HK, Cho SY, Cho SM, Lillehoj HS: Effects of dietary phytic acid on serum and hepatic lipid levels in diabetic KK mice. Nutr Res. 2005, 25: 869-876. 10.1016/j.nutres.2005.09.004.View Article
- Kumar V, Makkar HPS, Devappa RK, Becker K: Isolation of phytate from Jatropha curcas kernel meal and effects of isolated phytate on growth, digestive physiology and metabolic changes in Nile tilapia (Oreochromis niloticus L.). Food Chem Toxicol. 2011, 49: 2144-2156. 10.1016/j.fct.2011.05.029.View Article
- Onomi S, Okazaki Y, Katayama T: Effect of dietary level of phytic acid on hepatic and serum lipid status in rats fed a high-sucrose diet. Biosci Biotechnol Biochem. 2004, 68: 1379-1381. 10.1271/bbb.68.1379.View Article
- Lee HH, Rhee HI, Cha SH, Lee SY, Choi YS: Effects of dietary phytic acid on the lipid and mineral profiles in rats. Food Biotechnol. 1997, 6: 261-264.
- Lee SH, Park HJ, Chun HK, Cho SY, Jung HJ, Cho SM, Kim DY, Kang MS, Lillehoj HS: Dietary phytic acid improves serum and hepatic lipid levels in aged ICR mice fed ahigh-cholesterol diet. Nutr Res. 2007, 27: 505-510. 10.1016/j.nutres.2007.05.003.View Article
- Koba K, Lui JW, Bobik E, Mills DE, Sugano M, Huang YS: Effect of phytate in soy protein on the serum and liver cholesterol levels and liver fatty acid profile in rats. Biosci Biotechnol Biochem. 2003, 67: 15-22. 10.1271/bbb.67.15.View Article
- Urbano G, López-Jurado M, Aranda P, Vidal-Valverde C, Tenorio E, Porres J: The role of phytic acid in legumes: antinutrient or beneficial function?. J Physiol Biochem. 2000, 56: 283-294. 10.1007/BF03179796.View Article
- Gupta RK, Gangoliya SS, Singh NK: Reduction of phytic acid and enhancement of bioavailable micronutrients in food grains. J Food Sci Technol. 2013, DOI 10.1007/s13197-013-0978-y
- Hídvégi M, Lásztity R: Phytic acid content of cereals and legumes and interaction with proteins. Periodica Polytechnica Ser Chem Eng. 2002, 46: 59-64.
- Schlemmer U, Frølich W, Prieto RM, Grases F: Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis. Mol Nutr Food Res. 2009, 53: S330-S375. 10.1002/mnfr.200900099.View Article
- Pallauf J, Rimbach G: Nutritional significance of phytic acid and phytase. Arch Tierernahr. 1997, 50: 301-319. 10.1080/17450399709386141.View Article
- Rimbach G, Pallauf J: Phytic acid inhibits free radical formation in vitro but does not affect liver oxidant or antioxidant status in growing rats. J Nutr. 1998, 128: 1950-1955.
- Bozsik A, Kokeny S, Olah E: Molecular mechanisms for the antitumor activity of inositol hexakisphosphate (IP6). Cancer Genomics Proteomics. 2007, 4: 43-51.
- Nutescu EA, Shapiro NL: Ezetimibe: a selective cholesterol absorption inhibitor. Pharmacotherapy. 2003, 23: 1463-1474. 10.1592/phco.23.14.1463.31942.View Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.